$1.645
-0.053 (-3.24%)At close
- High
- 1.720
- Open
- 1.630
- VWAP
- 1.67
- Volume
- 6.05K
- Mkt Cap
- —
- Low
- 1.630
- Amount
- 10.07K
- EV/EBITDA, TTM
- 0.00
iTonic Holdings Ltd, formerly Pheton Holdings Ltd, is a holding company principally engaged in the provision of healthcare solutions through its subsidiary Beijing Feitian Zhaoye Technology Co., Ltd. (Beijing Feitian). The Company’s main businesses include development and commercialization of brachytherapy treatment planning system (TPS) specifically used for radioactive particle implantation, a type of radiotherapy used in treating cancer patients by placing radioactive sources inside the patient that kill cancer cells and shrink tumors. TPS is generally a computer software used in different types of radiotherapy. The Company’s main product is FTTPS, a user-oriented TPS for treating a wide variety of malignant tumors. Beijing Feitian’s product portfolio also includes Medical Auxiliary Supplies such as seed implant needles, computer workstations, patient positioning device and others.
AI analysis of iTonic Holdings Ltd (ITOC)
SelliTonic Holdings Ltd (ITOC) is not a good buy right now due to its extremely low RSI of 16.645, indicating it is oversold, and a staggering year-to-date change of -88.61%.
Valuation Metrics
Events Timeline
News
2.009-24PRnewswireClass Action Lawsuit Filed Against iTonic Holdings Ltd
7.009-23PRnewswireiTonic Holdings Faces Securities Class Action Over Disclosure Failures
7.009-15PRnewswireiTonic Holdings Ltd Faces Securities Class Action Over Fraud Allegations
7.009-10PRnewswireClass Action Lawsuit Filed Against iTonic Holdings Ltd
7.009-09PRnewswireiTonic Holdings Faces Class Action Over Disclosure Failures
ITOC FAQ — answered by Alphio AI
iTonic Holdings Ltd, formerly Pheton Holdings Ltd, is a holding company principally engaged in the provision of healthcare solutions through its subsidiary Beijing Feitian Zhaoye Technology Co., Ltd. (Beijing Feitian). The Company’s main businesses include development and commercialization of brachytherapy treatment planning system (TPS) specifically used for radioactive particle implantation, a type of radiotherapy used in treating cancer patients by placing radioactive sources inside the patient that kill cancer cells and shrink tumors. TPS is generally a computer software used in different types of radiotherapy. The Company’s main product is FTTPS, a user-oriented TPS for treating a wide variety of malignant tumors. Beijing Feitian’s product portfolio also includes Medical Auxiliary Supplies such as seed implant needles, computer workstations, patient positioning device and others. It operates in the Healthcare sector.
iTonic Holdings Ltd (ITOC) is not a good buy right now due to its extremely low RSI of 16.645, indicating it is oversold, and a staggering year-to-date change of -88.61%.
Community
More ↗No posts yet
Sign up or log in to join the discussionRelated articles
- How to Rebalance a Concentrated Stock Portfolio in 2026: Mag7 Drift, Tax-Aware Trims, and Practical Rebalance a concentrated stock portfolio in 2026: Mag7 drift risk, 5pp bands, tax-aware trims, RSP/IWM diversifiers, and single-name caps.
- Small Cap Stocks Investing Guide 2026: Russell 2000, Fed Hikes, and the Financing TradeSmall-cap stocks investing guide 2026: Russell 2000 vs S&P, IWM rate sensitivity, floating-rate debt, Fed hikes, valuation discounts, and a practical checklist.
- Santa Claus Rally and the Year-End Stock Market: Investor Guide for Late 2026Santa Claus rally explained: 7-day window stats since 1950, Nov–Dec seasonality, post-midterm 2026 setup, and a risk-managed year-end investing playbook.
This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.